A cell death program-based tumor signature stratifies prognosis, immune landscape, and therapeutic response in glioma.

Front Oncol · 2026 · PMC13233278 · PMID 42255240

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Based on their PA scores, TCGA patients revealed a highly significant difference in overall survival (OS), with patients in the high-risk group exhibiting markedly poorer prognosis compared to those in the low-risk group ( Figure 2K , Log-rank P < 0.0001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.